EU approves AstraZeneca immunotherapy drug for lung cancer
The green light from the EU had been expected following a positive recommendation from experts at the European Medicines Agency
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
USFDA completes inspection of Biocon’s drug substance unit at Bengaluru
The week-long audit concluded without any observations and no Form 483 was issued
Our research aims to develop low-cost efficient anti-cancer therapeutic options: Dr P Gopinath
IIT Roorkee Professor Dr P Gopinath discusses about developing an economical and green way to detect and kill cancer cells and how…
Kaisha launches Kaisha Lifesciences at Daman, India
In addition to the products offered by Kaisha Lifesciences, the new set-up will offer a portfolio of contract research services…
Bayer says Monsanto India integration to complete in one year
Bayer completed the deal to acquire US-based Monsanto recently and the acquisition of Monsanto has been completed globally but it…
Cipla receives final approval for generic version of Impax Laboratories, Albenza
It is an anthelmintic drug indicated for use in treatment of parenchymal neurocysticercosis
Biocon and Mylan announce positive CHMP opinion for Fulphila, Biosimilar Pegfilgrastim
Fulphila was approved by the US FDA earlier this year and is the first FDA-approved biosimilar for Neulasta in the US
Centaur Pharma concludes 10th common cold awareness week campaign
Centaur has been undertaking the 'Common Cold Awareness Week' campaign to prevent people from self medication and encourage them…
Sun Pharma gets Australia TGA nod for plaque psoriasis treatment drug
Sun Pharma is to launch a patient support programme to assist patients prescribed with this drug
Schott Kaisha hosts pharma packaging stalwarts at its Jambusar plant, Gujarat
More than 60 delegates took part in the half-day visit to Schott Kaisha’s state-of-the-art facility